优化基于醚和苯胺的乳酸脱氢酶抑制剂。
Optimization of ether and aniline based inhibitors of lactate dehydrogenase.
机构信息
Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, United States.
National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States.
出版信息
Bioorg Med Chem Lett. 2021 Jun 1;41:127974. doi: 10.1016/j.bmcl.2021.127974. Epub 2021 Mar 24.
Abstract
Lactate dehydrogenase (LDH) is a critical enzyme in the glycolytic metabolism pathway that is used by many tumor cells. Inhibitors of LDH may be expected to inhibit the metabolic processes in cancer cells and thus selectively delay or inhibit growth in transformed versus normal cells. We have previously disclosed a pyrazole-based series of potent LDH inhibitors with long residence times on the enzyme. Here, we report the elaboration of a new subseries of LDH inhibitors based on those leads. These new compounds potently inhibit both LDHA and LDHB enzymes, and inhibit lactate production in cancer cell lines.
摘要
乳酸脱氢酶（LDH）是糖酵解代谢途径中的关键酶，许多肿瘤细胞都在使用。LDH 的抑制剂有望抑制癌细胞的代谢过程，从而选择性地延迟或抑制转化细胞与正常细胞的生长。我们之前已经披露了一系列基于吡唑的强效 LDH 抑制剂，这些抑制剂在酶上的停留时间很长。在这里，我们报告了基于这些先导化合物的新的 LDH 抑制剂亚系列的阐述。这些新化合物强烈抑制 LDHA 和 LDHB 两种酶，并抑制癌细胞系中的乳酸生成。
相似文献
1
Optimization of ether and aniline based inhibitors of lactate dehydrogenase.优化基于醚和苯胺的乳酸脱氢酶抑制剂。
Bioorg Med Chem Lett. 2021 Jun 1;41:127974. doi: 10.1016/j.bmcl.2021.127974. Epub 2021 Mar 24.
2
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).基于吡唑的高效、细胞活性乳酸脱氢酶（LDH）抑制剂的发现与优化
J Med Chem. 2017 Nov 22;60(22):9184-9204. doi: 10.1021/acs.jmedchem.7b00941. Epub 2017 Nov 9.
3
Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.吡咯-2-基乙酮衍生物对乳酸脱氢酶的抑制作用及抗癌活性评估。
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Aug 5;165:21-25. doi: 10.1016/j.saa.2016.04.010. Epub 2016 Apr 13.
4
Synthesis of 1-Hydroxy(and 1-Alkoxy, 1-Acyloxy)-1H-indoles and evaluations of their suppressive activities against tumor growth through inhibiting lactate dehydrogenase A.1-羟基（以及1-烷氧基、1-酰氧基）-1H-吲哚的合成及其通过抑制乳酸脱氢酶A对肿瘤生长抑制活性的评估。
Eur J Med Chem. 2025 Feb 5;283:117104. doi: 10.1016/j.ejmech.2024.117104. Epub 2024 Nov 30.
5
Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay.人乳酸脱氢酶 A 抑制剂的开发：高通量筛选、分子动力学模拟和酶活性测定。
J Comput Aided Mol Des. 2024 Aug 10;38(1):28. doi: 10.1007/s10822-024-00568-y.
6
Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer.乳酸脱氢酶-A 抑制剂的合成及对胰腺癌的生物学特性研究
Eur J Med Chem. 2024 Sep 5;275:116598. doi: 10.1016/j.ejmech.2024.116598. Epub 2024 Jun 17.
7
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.双重基因敲除乳酸脱氢酶 A 和 B 是消除“Warburg 效应”所必需的，该效应限制了肿瘤生长到氧化代谢。
J Biol Chem. 2018 Oct 12;293(41):15947-15961. doi: 10.1074/jbc.RA118.004180. Epub 2018 Aug 29.
8
Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment.乳酸脱氢酶抑制独立于细胞代谢状态影响同源重组修复；对癌症治疗的启示。
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129760. doi: 10.1016/j.bbagen.2020.129760. Epub 2020 Oct 7.
9
Identification of the first highly selective inhibitor of human lactate dehydrogenase B.鉴定人乳酸脱氢酶 B 的第一个高选择性抑制剂。
Sci Rep. 2021 Nov 1;11(1):21353. doi: 10.1038/s41598-021-00820-7.
10
Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner.外源性丙酮酸过量以依赖 MCT1 的方式抑制活细胞中的乳酸脱氢酶活性。
J Biol Chem. 2021 Jul;297(1):100775. doi: 10.1016/j.jbc.2021.100775. Epub 2021 May 20.
引用本文的文献
1
Metabolic reprogramming in cancer and senescence.癌症与衰老中的代谢重编程。
MedComm (2020). 2025 Mar 4;6(3):e70055. doi: 10.1002/mco2.70055. eCollection 2025 Mar.
2
Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria.用于原发性高草酸尿症的双乙醇酸氧化酶/乳酸脱氢酶A抑制剂
ACS Med Chem Lett. 2021 May 20;12(7):1116-1123. doi: 10.1021/acsmedchemlett.1c00196. eCollection 2021 Jul 8.
本文引用的文献
1
Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties.基于吡唑的乳酸脱氢酶抑制剂，具有优化的细胞活性和药代动力学性质。
J Med Chem. 2020 Oct 8;63(19):10984-11011. doi: 10.1021/acs.jmedchem.0c00916. Epub 2020 Sep 27.
2
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).基于吡唑的高效、细胞活性乳酸脱氢酶（LDH）抑制剂的发现与优化
J Med Chem. 2017 Nov 22;60(22):9184-9204. doi: 10.1021/acs.jmedchem.7b00941. Epub 2017 Nov 9.
3
Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions.钯催化的碳-氮交叉偶联反应的应用
Chem Rev. 2016 Oct 12;116(19):12564-12649. doi: 10.1021/acs.chemrev.6b00512. Epub 2016 Sep 30.
4
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.代谢可塑性为 LDHA 抑制的先天和获得性耐药提供了基础。
Nat Chem Biol. 2016 Oct;12(10):779-86. doi: 10.1038/nchembio.2143. Epub 2016 Aug 1.
5
An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software.一种使用集成高分辨率精确质量法和自动化数据分析软件的自动化高通量代谢稳定性测定方法。
Drug Metab Dispos. 2016 Oct;44(10):1653-61. doi: 10.1124/dmd.116.072017. Epub 2016 Jul 14.
6
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways.通过（i）p53/NAD(H) 依赖性和（ii）p53 非依赖性途径鉴定 LDH-A 作为杀伤癌细胞的治疗靶点。
Oncogenesis. 2014 May 12;3(5):e102. doi: 10.1038/oncsis.2014.16.
7
Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.靶向乳酸脱氢酶——抑制肺癌小鼠模型中的肿瘤发生和肿瘤进展，并影响肿瘤起始细胞。
Cell Metab. 2014 May 6;19(5):795-809. doi: 10.1016/j.cmet.2014.03.003. Epub 2014 Apr 10.
8
Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.乳酸脱氢酶-A在人肝内胆管癌中的过表达：其对治疗的意义。
World J Surg Oncol. 2014 Mar 31;12:78. doi: 10.1186/1477-7819-12-78.
9
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells.喹啉 3-磺胺抑制乳酸脱氢酶 A 并逆转癌细胞中的有氧糖酵解。
Cancer Metab. 2013 Sep 6;1(1):19. doi: 10.1186/2049-3002-1-19.
10
Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.乳酸脱氢酶A在胰腺癌中过度表达，并促进胰腺癌细胞的生长。
Tumour Biol. 2013 Jun;34(3):1523-30. doi: 10.1007/s13277-013-0679-1. Epub 2013 Feb 13.
Zotero 插件